BRIEF-Haemonetics Q4 GAAP loss per share $0.17
May 02, 2016 at 07:05 AM EDT
* Haemonetics reports 4th quarter fiscal 2016 revenue of $243 million, constant currency revenue growth of 10% and 7% as reported; fiscal 2016 revenue of $910 million, constant currency revenue growth of 3% and flat as reported